1Comella P. Southern Italy Cooperative Oncology Group. Phase Ⅲ trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer[J] .Semin Oncol,2001,28(2 Suppl 7):7-10.
2Souquet PJ,Tan EH,et al.A prospective randomised clinical phase Ⅲtrial comparing vinorlbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients[J]. Ann Oncol,2002Dec, 13(12): 1853-1861.
3Von Pawel J,von Roemeling R, Gatzemeier U,et al. Tirapazamine plus Cisplatin versus cisplatin in advanced non-small-cell lung cancer: a report of the international CATAPULT I study group [ J ]. J Clin Oncol,2000,18:1351-1359.
4AG Pallis, D Marvroudis, N Androulakis, et al. ZD 1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer, Experience from a single center participating in a
5Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone, et al. Multi-institutional randomized phase Ⅱ trial of gefitinib for previously treated patient with advanced non-small-cell lung cancer[J]. Clin Oncol, 2003,21:2237-2246.
6Socinski MA,Schell MJ,Peterman A,et al. Phase Ⅲtrial comparing a defined druation of therapy versus continuous therapy followed by second-line therapy in advanced-stage Ⅲ B/Ⅳ non-small-cell lung cancer [J] .J Clin Oncol,2002 Mar 1,20(5):1335-1343.
7Le Chevalier T, Brisgand D, Douillard JY, et al. Randomized study of vinorebine and cisplatin versus vinorebine and cisplatin versus vinorebine alone in advanced non-small cell lung cancer:results of European multicenter trail including 612 patients[J] .J
8Kelly K, Crowley J, Bunn PA,jt, et al Randomized phase Ⅲ trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: A Southwest Oncology Group Trail [ J ]. J Clin Oncol, 2
9RP Pemg,YM Chen,J Ming-Liu,et al. Gemcitabine versus the combination of sisplatin and etoposide in patients with inoperable non-smallcell lung cancer in a phase Ⅱ randomized study [ J ]. J. Clin Oncol 1997,15:2097-2102.
10S. kakolyris, X. Tsiafaki, A. Agelidou, et al. Preliminary results of a multicenter randomized phase Ⅲ trial of docetaxel plus gemcitabine (DC) versus vinorebine plus cisplatin (VC)in patients with advanced non-small cell lung cancer[J]. The Greek Coopea
